Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax-based Regimen in Newly Diagnosed CBFβ::MYH11-positive AML
NCT06429098Phase 2Active, not recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jan 2024
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax in acute myeloid leukemia (AML), sponsored by First Affiliated Hospital of Soochow University. Started Jan 2024; status: active, not recruiting.
02
Drugs
venetoclax
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT06429098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06429098.